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Ataxia with oculomotor apraxia (AOA) is characterized by early-onset cerebellar ataxia, ocular apraxia, early
areflexia, late peripheral neuropathy, slow progression, severe motor handicap, and absence of both telangiectasias
and immunodeficiency. We studied 13 Portuguese families with AOA and found that the two largest families show
linkage to 9p, with LOD scores of 4.13 and 3.82, respectively, at a recombination fraction of 0. These and three
smaller families, all from northern Portugal, showed homozygosity and haplotype sharing over a 2-cM region on
9p13, demonstrating the existence of both a founding event and linkage to this locus, AOA1, in the five families.
Three other families were excluded from this locus, demonstrating nonallelic heterogeneity in AOA. Early-onset
cerebellar ataxia with hypoalbuminemia (EOCA-HA), so far described only in Japan, is characterized by marked
cerebellar atrophy, peripheral neuropathy, mental retardation, and, occasionally, oculomotor apraxia. Two unrelated
Japanese families with EOCA-HA were analyzed and appeared to show linkage to the AOA1 locus. Subsequently,
hypoalbuminemia was found in all five Portuguese patients with AOA1 with a long disease duration, suggesting
that AOA1 and EOCA-HA correspond to the same entity that accounts for a significant proportion of all recessive
ataxias. The narrow localization of AOA1 should prompt the identification of the defective gene.
The hereditary ataxias are a heterogeneous group of dis-
eases characterized by cerebellar ataxia associated with
a number of different neurological, ophthalmological,
or general signs. These diseases represent 10% of ner-
vous-system genetic disorders. In 1988, Aicardi et al.
(1988) reviewed 14 ataxic patients, including six cases
previously reported in Japan, United Arab Emirates, and
Portugal (Inoue et al. 1971; Araie et al. 1977; Morcos
et al. 1982; Awaya et al. 1985, 1986), all of whom had
a neurological presentation similar to that of ataxia-
telangiectasia (AT [MIM 208900]), but without any of
its extraneurological features. In fact, the presence of
oculomotor apraxia, defined as the limitation of ocular
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movements on command, dissociated from pursuit
movements, is a major clinical feature of this pathology
(Barbot et al., in press), as it is in AT and in spinocer-
ebellar ataxia type 2 (SCA2 [MIM 601517]). This new
form of recessive ataxia with oculomotor apraxia (AOA
[MIM 208920]) was considered rare, and few reports
were published thereafter. In 1992, Uekawa et al. pre-
sented cases of early-onset cerebellar ataxia with hy-
poalbuminemia (EOCA-HA) in three Japanese consan-
guineous families. Several similar reports were subse-
quently made in Japan (Fukuhara et al. 1995; Kubota
et al. 1995; Sekijima et al. 1998; Tachi et al. 2000),
including one in which oculomotor apraxia and cho-
reoathetosis were noted in two sibs after 13 years of
disease duration (Hanihara et al. 1995). Mental retar-
dation was noted in several patients (Fukuhara et al.
1995; Sekijima et al. 1998; Tachi et al. 2000). Except
for the presence of mental retardation, these Japanese
forms of ataxia showed a remarkable clinical resem-
blance to AOA.
In Portugal, fourteen families with AOA (24 living

Figure 1 Simplified pedigrees of the families with AOA that show linkage to 9p13, and of family AOAP9. Markers are shown, from top
to bottom, in their pter-qter order (from GeneMap’99). Haplotypes linked to the disease are boxed, and homozygosity in patients is shaded in
gray. Distance (cM) to the previous marker is indicated before each marker (Fondation Jean Dausset–CEPH; The Sanger Centre). Markers that
were part of the initial whole-genome screening are underlined. ntpnot tested. The 5′ allele of D9S1791 is intermediate between alleles 5 and
6 (a single-nucleotide variation).
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Table 1
Two-point LOD Scores of AOA, for the D9S1817-D9S1878 Haplotype, in Portuguese and Japanese
Families Sharing Founding Haplotypes
FAMILY
LOD SCORE AT v pa
0 .01 .05 .1 .2 .3 .4
Portuguese:
AOAP1 4.13 4.05 3.73 3.32 2.46 1.58 .73
AOAP4 3.82 3.75 3.49 3.14 2.41 1.63 .84
AOAP5 1.74 1.70 1.56 1.38 1.01 .65 .30
AOAP7 2.42 2.37 2.15 1.88 1.30 .73 .26
AOAP11 .90 .88 .79 .68 .46 .26 .11
Total 13.01 12.75 11.72 10.40 7.64 4.85 2.24
Japanese:
AOAJ1 2.34 2.29 2.12 1.89 1.42 .94 .46
AOAJ2 2.34 2.29 2.12 1.89 1.42 .94 .46
Total 4.68 4.58 4.24 3.78 2.84 1.88 .92
a A gene frequency of .005 and a linked haplotype frequency of ∼7#104 (calculated as the product
of the frequency of the individual alleles estimated in the reference populations) were used for LOD-score
calculations. Control samples, representing 45 Portuguese and 34 Japanese independent chromosomes,
were analyzed for estimation of allele frequencies. Minimal LOD-score values are given for families
(AOAP4, -P5, -J1, and -J2) with ancient nondocumented consanguinity, for whom second-degree consan-
guinity was assumed.
Figure 2 Haplotypes in families AOAP1, -P4, -P5, -P7, -P11, and -P9 and in AOAJ1 and -J2. Homozygous alleles are indicated only once
per family. Alleles homozygous by descent are in boldface. The shared haplotypes are boxed and shaded in gray. Alleles that might belong to
the founding haplotypes are boxed with dotted lines. Allele 13 from marker D9S1817 (in family AOAP5) might diverge from the founding
haplotype by recombination or might derive from the founding allele (12) by slippage mutation of the marker. Phase in family AOAJ1 could
not be inferred, since samples of the parents were not available. The dotted box above AOAJ1 and -J2 indicates that one haplotype of AOAJ1
might be identical to the homozygous AOAJ2 haplotype.
patients) had been identified (relative frequency of
13.8% of all recessive ataxias in Portugal). The majority
were ascertained during a systematic population-based
survey of hereditary ataxias and spastic paraplegias that
has been conducted in Portugal since 1993 (Silva et al.
1997). This survey already has been completed in 12/
18 districts in mainland Portugal and onMadeira Island,
including a total population of 5,288,510 inhabitants.
The remaining patients were referred by their neurol-
ogists.
Families AOA-P1 through -P11 have been described
elsewhere (Barbot et al., in press). All patients presented
with progressive cerebellar ataxia starting at 1–15 years
of age (mean age p 5 years), axonal neuropathy, and
oculomotor apraxia, which was usually noticed a few
years after the onset of gait ataxia. Through use of mag-
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Figure 3 Geographical distribution, on the Portuguese main-
land, of families with AOA. Districts where the survey is already com-
pleted are shaded in gray. Family AOAP13 is not represented, because
of its African (Cabo Verde) origin. The three families in the Braga
region that show linkage to 9p are AOAP4, -P7, and -P11, which share
the largest region of linkage disequilibrium (fig. 2).
netic-resonance imaging, cerebellar atrophy was found in
all patients studied. None had mental retardation, tel-
angiectasia, or immunodeficiency, which excluded the di-
agnosis of AT. Disease progression was slow and com-
patible with long survival, despite severe motor handicap.
All three patients in family AOAP10 had optic atrophy
beginning late in life. The two patients of family AOAP9
and the one patient of AOAP2 had early dystonia, as-
sociated with mask-like facies (Barbot et al., in press).
Patients from families AOAP13 (originating from Cabo
Verde, an ancient Portuguese colony) and AOAP14 also
fulfilled the diagnostic criteria for AOA, as defined by
Barbot et al. (in press), whereas the patient from family
AOAP12 had an atypical presentation (pyramidal signs,
spasticity, hyperreflexia, and ankle clonus) and was ex-
cluded from the linkage study. A diagnosis of Friedreich
ataxia (MIM 229300) was excluded in all cases, by a
molecular test. Families AOAP1, -P3, -P7, -P10, -P11, and
-P13 were documented as consanguineous, and family
-P13 was suspected to have ancient consanguinity. Ap-
propriate informed consent and blood samples were ob-
tained from available family members. The study was
approved by the ConselhoNacional de E´tica para asCieˆn-
cias da Vida and by the Commissa˜o de E´tica do Hospital
Geral de Santo Anto´nio-Porto.
Five informative Portuguese families (AOAP1, -P3,
-P4, -P9, and -P10) were screened for linkage with the
markers of the ABI PRISM Linkage Mapping Set, ver-
sion 2 (PE Biosystems). These markers were selected
from the Ge´ne´thon human linkage map (Dib et al. 1996)
and are spaced every 10 cM, on average. We looked for
markers that segregated, with a minimum of recombi-
nation events, with the disease and that showed ho-
mozygosity in the consanguineous families (AOAP1,
-P3, and -P10). No such marker was found, suggesting
genetic heterogeneity among the five families. The largest
family, AOAP1, was then analyzed separately. Only one
marker, D9S1817, showed no recombination and was
homozygous in the two affected grandaunts and in the
affected grandniece, all born from consanguineous par-
ents (fig. 1). Moreover, the two distal markers (D9S273
and D9S175), which were, respectively, 7 cM and 12
cM distant, were also homozygous in the grandaunts,
suggesting a larger region of homozygosity, a phenom-
enon related to the closer consanguinity of their parents.
A denser set of chromosome 9 (pericentromeric and
proximal short-arm) markers flanking D9S1817 was
then analyzed in this family (Dib et al. 1996; Ge´ne´thon).
A 2-cM region of six consecutive markers on 9p13 (the
D9S1878-D9S1817 haplotype) was found to be ho-
mozygous in all three patients (fig. 1). Larger regions of
homozygosity were found in one of the grandaunts and
in the grandniece. LOD-score calculation, including the
consanguinity loops (Lathrop et al. 1985; Ben Hamida
et al. 1993), gave a value of 4.13 at a recombination
fraction (v) of 0, indicating linkage between the disease
and the D9S1878-D9S1817 haplotype (table 1).
All other Portuguese families with AOAwere analyzed
with respect to the same region on chromosome 9. Two
other consanguineous families (AOAP7 and -P11), as
well as families in whom consanguinity was not sus-
pected (AOAP4 and -P5), showed homozygosity over
regions containing the D9S1878-D9S1817 haplotype
(fig. 1). In addition, segregation among the 10 children
in AOAP4 indicated linkage to 9p13 (fig. 1). The final
argument in favor of linkage in the five homozygous
families was the sharing of the D9S1878-D9S1817 hap-
lotype between families AOAP1, -P4, -P7, and -P11, and
of a shorter, four-marker haplotype between these four
families and family AOAP5 (fig. 2), strongly suggesting
an ancient founding event. The inference of a common
founding ancestor is in agreement with the origin of all
five families in northern Portugal (fig. 3). This result led
to the conclusion that AOA is genetically homogeneous
among the five families and that the LOD scores could
be combined for linkage purposes; this approach yielded
a cumulative LOD score of 13.01 at v p 0 (table 1).
Linkage in families AOAP6, -P10, and -P13 was ex-
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Table 2
Serum Albumin and Total-Cholesterol Values, According to Linkage Status and Disease Duration
Family
Status of
Linkage to 9p13 Patienta
Disease Duration at
Time of Sampling
(years)
Serum Albuminb
(g/dl)
Total Cholesterolc
(mM)
AOAP1 Linked 1 5 … Normal
2 58 2.3 11
3 38 2.5 8.2
AOAP2 Unknown 4 7 4.2d 4.7
4 10 4.4d 5.6
AOAP3 Unknown 5 14 3.0 5
AOAP4 Linked 8 17 3.2d …
8 18 2.7d 5.2
AOAP5 Linked 12 15 3.5 3.8
AOAP6 Not linked 13 8 4.2 5.1
14 15 3.7 4.3
AOAP7 Linked 15 11 3.8 5.6
AOAP8 Unknown 16 19 2.8 …
AOAP9 Unknown 17 20 2.7 7.6
18 23 2.5 5.4
AOAP10 Not linked 20 52 4.1 5.2
AOAP11 Linked 22 21 3.4 7.3
AOAJ1e Linked 1 26 2.9 6.5
2 25 3.0 6.2
3 19 2.7 6
AOAJ2e Linked 4 18 2.9 6.8
5 14 2.8 6.2
a Numbering according to Barbot et al. (in press), for AOAP, and Tachi et al. (2000) for AOAJ.
b Normal values range from 3.7 to 5.1 g/dl.
c Normal values range from 3.6 to 5.6 mM.
d Serum albumin in patients 4 and 8 was measured at two different times.
e Serum albumin and total cholesterol values, from Tachi et al. (2000), are reported here for comparison.
cluded for this locus, since the two affected sibs in each
family were discordant over the entire region from
D9S1876 to D9S1853 (data not shown). In addition, the
patients of families AOAP10 and -P13 showed no ho-
mozygosity over the critical interval despite consanguin-
ity of the parents, further supporting the conclusion that
nonallelic genetic heterogeneity is present among the
Portuguese patients. The locus on 9p13 was named
“AOA1”. In the other five families (AOAP2, -P3, -P8,
-P9, and -P14), we could make no conclusions about
linkage to 9p13. Family AOAP3 may be excluded, since
the single affected child is not homozygous for the crit-
ical interval despite second-degree consanguinity of the
parents. Family AOAP9 had a LOD score of 0.75, sup-
porting linkage. The maternal chromosome in each of
the two patients shared alleles 3–11 of D9S1805-
D9S165 with the Portuguese ancestral founding hap-
lotype (fig. 2). The identification of additional markers
is needed to establish whether AOAP9 is related to the
same Portuguese founding event. The frequency of the
four-allele founding haplotype in families showing link-
age to 9p13 and in families with unknown linkage status
was compared with the estimated frequency of this hap-
lotype in the control group by the x2 test of homogeneity;
a statistically significant difference was found (P !
), confirming the presence of linkage disequilibrium..001
Four Japanese patients (cases 2–5 in Tachi et al. 2000)
belonging to two families (here referred to as “AOAJ1”
and “AOAJ2”), were subsequently analyzed. Patients 2
and 3 are sister and brother. Their older affected sister
(patient 1) is deceased, and no DNA sample was avail-
able. Patients 4 and 5 are sisters. Consanguinity has not
been documented in either of the families, which are not
related to one another, although they both originate
from Hokkaido Prefecture. The patients presented with
recessive cerebellar ataxia with early onset (at age 2–5
years), hypoalbuminemia, peripheral neuropathy, and
mild to moderate mental retardation (Tachi et al. 2000).
The five patients had marked atrophy of the cerebellum.
Patients 1–3 had pes cavus; none had scoliosis or dys-
tonia. On further examination, all five patients also pre-
sented with oculomotor apraxia (K. Sasaki, personal
communication). The two patients in each family were
concordant for segregation of the AOA1 locus. In ad-
dition, the patients in family AOAJ2 were homozygous
over a 14-marker haplotype, and the patients in family
AOAJ1 were homozygous over an 8-marker haplotype
(fig. 2), indicating ancient consanguinity. When second-
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degree or more-distant consanguinity was assumed, the
combined LOD score supporting linkage for AOAJ1 and
AOAJ2was4.68 (table 1).Moreover, the two Japanese
haplotypes were identical over five contiguous markers,
which again suggested the existence of a common an-
cestor (fig. 2). Taken together, the data indicate that the
loci for AOA1 and EOCA-HA are located within the
same interval and that they may result from mutations
in the same gene.
Levels of serum albumin and of total cholesterol,
which are reduced and increased, respectively, in patients
with EOCA-HA who have a long disease duration (Ha-
nihara et al. 1995; Tachi et al. 2000), were subsequently
measured in several Portuguese patients with AOA (table
2). Levels of serum albumin were indeed reduced in all
five patients with AOA1 who had 15 years of disease
duration, whereas levels of total serum cholesterol were
high in three patients and were normal in two. In con-
trast, two patients (14 and 20) who were from families
showing no linkage to AOA1 and who also had 15
years of disease duration, were found to have both levels
of serum albumin and levels of total cholesterol within
the normal range.
Several recombinations in phase-known haplotypes,
as well as recombinations inferred from heterozygos-
ity in patients born from consanguineous parents, place
the AOA1 locus between D9S1791 (proximal) and
D9S1853 (distal). In addition, the historic recombina-
tion in family AOAJ1 also involves marker D9S1817
(fig. 2), indicating that it is the proximal marker closest
to the AOA1 locus. On the other hand, comparison of
the five Portuguese families that share an ancestral hap-
lotype also points to the occurrence of a historic recom-
bination involving D9S1878, on the distal side (fig. 2).
The estimated genetic distance between D9S1817 and
D9S1878 is ∼2 cM. The gene encoding cytosolic acon-
itase (also known as “IRE-BP1”) is located close to
D9S1878 and appears to be a good candidate gene for
AOA1, since IRE-BP1 controls cytosolic iron homeosta-
sis (Gray et al. 1993; Hirling et al. 1994), and cytosolic
aconitase is secondarily inactivated in Friedreich ataxia
(Ro¨tig et al. 1997). We identified two CA/TG micro-
satellite polymorphisms in a bacterial-artificial-chro-
mosome clone, RP11–334P12 (GenBank), containing
IRE-BP1 (primer pairs MS1IRE-BP1 [5′-ctttggtctactata-
agcc-3′ and 5′-cacttgtagtttttccatc-3′] and MS2IRE-BP1
[5′-gtctctagtaagaacatac-3′ and 5′-ctctaaaacagtgatcctc-3′]),
and tested them on the Portuguese and Japanese families
with AOA. The recombinations indicated that IRE-BP1
is excluded from the AOA1 critical interval and is lo-
cated just distal to D9S1878 (fig. 2).
AOA has been recognized in diverse populations, in-
cluding in the Japanese population (Inoue et al. 1971;
Araie et al. 1977; Awaya et al. 1985, 1986; Aicardi et
al. 1988) and, so far, appears to represent the second-
most-common cause of recessive ataxia in Portugal
(Moreira et al. 1999; Barbot et al., in press). On the
other hand, a new entity, EOCA-HA, is receiving grow-
ing attention in Japan (Uekawa et al. 1992; Fukuhara
et al. 1995; Hanihara et al. 1995; Sekijima et al. 1998;
Tachi et al. 2000). In the present study we have identified
the AOA1 locus on 9p13 in a significant portion of the
Portuguese families, and we have demonstrated locus
heterogeneity in AOA. Surprisingly, we found that two
Japanese families with EOCA-HA show linkage to the
same region. Clinical and biochemical reevaluation re-
vealed that our patients with EOCA-HA indeed had oc-
ulomotor apraxia and that the Portuguese patients with
AOA1 had hypoalbuminemia. It now becomes impor-
tant that all patients diagnosed with EOCA-HA be re-
evaluated for oculomotor apraxia and that all patients
diagnosed with AOA be reevaluated for hypoalbumi-
nemia and for hypercholesterolemia. None of these fea-
tures can, however, be regarded as diagnostic criteria in
early cases, since oculomotor apraxia usually develops
only a few years after the onset of cerebellar ataxia
(Barbot et al., in press), and since hypoalbuminemia is
marked only in patients in their 20s (Hanihara et al.
1995). Linkage analysis andmore-precise clinical criteria
for diagnosis of AOA1 should now allow for better di-
agnosis of the disease, and for an estimation of the in-
cidence of this condition worldwide.
The existence of genetic heterogeneity among patients
with AOA is likely to complicate the accurate diagnosis
of this condition. Among families that do not show link-
age to 9p13, patients from family AOAP6 are clinically
indistinguishable from patients with AOA1, whereas pa-
tients from family AOAP10 additionally show optic at-
rophy, found after extended duration of the disease in
all three patients (one deceased). On the other hand,
mental retardation does not seem to be either an exclu-
sion criterion or an inclusion criterion for AOA1, since
all five Japanese patients showing linkage had mild to
moderate mental retardation (Tachi et al. 2000), whereas
it was not a feature of the Portuguese patients (Barbot
et al., in press), suggesting possible allelic heterogeneity.
The precise mapping of the AOA1 locus within a 2-cM
region should prompt the identification of the defective
gene and of the corresponding mutations and should
therefore help to answer these questions.
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